<DOC>
	<DOCNO>NCT00404599</DOCNO>
	<brief_summary>Background : HMG-CoA reductase inhibitor ( statin ) effective lipid-lowering agent know reduce cardiovascular event . Beneficial effect statins seem occur early course therapy subgroup analysis large trial indicate subject statin-treated arm less cardiovascular event subject placebo-controlled arm comparable serum cholesterol level . Therefore , suggest statin may antiatherogenic effect beyond cholesterol lower effect . Many study demonstrate rapid improvement vascular function atorvastatine solely account achieve lipid reduction . A rapid oxidative stress lower effect atorvastatin propose probable mechanism action . Whether atorvastatine stronger antioxidant effect whether atorvastatin lower oxidative stress earlier course therapy statins study yet . Objective : To compare rapidity onset extent oxidative stress lower atorvastatin ( term LDL lower ) equipotent dosage simvastatin . Methods : We plan recruit sixty statin naive patient , diabetes mellitus type 2 and/or obesity ( BMI &gt; 25 ) and/or hypertension ( RR &gt; 140/90 mmHg ) . Patients K/DOQI stage 5 chronic kidney disease ( Cockcroft-Gault clearance less 15 ml/min/1.73m2 ) , patient use vitamin preparation , statin last three month patient LDL cholestrerol &lt; 2.5 mmol/l exclude study . Because influence angiotensin-converting enzyme inhibitor ( ACE-inhibitors ) oxidative stress , patient stratify prior ACE-inhibitor use randomization . All include patient randomize treatment simvastatin 40 mg daily atorvastatin 10 mg daily achieve comparable lipid reduction . Established parameter oxidative stress oxidize LDL , malondealdehyde isoprostane measure plasma inclusion , one week , six week three month inclusion . We also plan measure endothelial function parameter soluble Vascular Adhesion Molecule ( sVCAM ) von Willebrand factor . In addition , parameter inflammation high sensitive C - reactive protein , TNF-alfa , interleukin-6 myeloperoxidase measure investigate whether correlation oxidative stress lower endothelial function inflammation . The inhibitory effect HDL prevent oxidation LDL determine measurement lipid peroxide form vitro oxidation LDL co-incubated HDL . The inflammatory / anti-inflammatory property HDL test measurement HDL capacity inactivate oxidize palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine ( ox-PAPC ) . Collections 24 hour urine begin one week , six week three month use measure urine F2-isoprostane level . Analyses : All parameter oxidative stress treatment statin compare determine whether atorvastatin cause strong quick reduction oxidative stress simvastatin . Generalized estimate equation ( GEE ) use compare effect . We plan include minimum 30 patient treatment-group outpatient clinic department internal medicine VU University Medical Center Amsterdam . Expected result : Atorvastatin reduce oxidative parameter strong early simvastatin .</brief_summary>
	<brief_title>Oxidative Stress Lowering Effect Simvastatin Atorvastatin .</brief_title>
	<detailed_description>Background HMG-CoA reductase inhibitor ( statin ) effective lipid-lowering agent know reduce cardiovascular event . It initially assume cholesterol reduction statins mechanism responsible beneficial effect . However , beneficial effect statins seem occur early course therapy [ 1 ] subgroup analysis large trial indicate subject statin-treated arm less cardiovascular event subject placebo-controlled arm comparable serum cholesterol level [ 2 ] . Therefore , suggest statin may antiatherogenic effect , anti-inflammatory antioxidative action , beyond cholesterol lower effect . Many study demonstrate rapid improvement vascular function atorvastatine solely account achieve lipid reduction [ 3-5 ] . In Pravastatin Atorvastatin evaluation infection therapy-thrombolysis myocardial infarction 22 trial ( PROVE-IT-TIMI 22 trial ) , follow-up period 2-years intensive statin therapy , 80 mg atorvastatin show strong reduction cardiovascular event compare 40 mg pravastatin , apparent benefit observe early [ 6 ] . A rapid strong oxidative stress lower effect atorvastatin propose probable mechanism action [ 7 ] . Other statin show anti-oxidant effect well [ 8,9 ] . However , whether atorvastatine stronger antioxidant effect whether atorvastatin lower oxidative stress early course therapy statins demonstrate . Hypothesis : Atorvastatin show rapid strong antioxidative effect compare simvastatin . Study objective The objective study compare oxidative stress lower capacity atorvastatin , widely use statin US , simvastatin population patient increase oxidative stress ( patient diabetes mellitus [ 10 ] , hypertension [ 11 ] obesity [ 12 ] chronic kidney disease [ 13 ] know increased oxidative stress ) . Design methods We plan recruit sixty statin naive patient diabetes mellitus type-2 and/or obesity ( BMI &gt; 25 kg/m2 ) and/or hypertension ( RR &gt; 140/90 mmHg ) . Patients K/DOQI stage 5 chronic kidney disease ( Cockcroft-Gault clearance less 15ml/min/1.73m2 ) patient use vitamin preparation statin last three month exclude study . Because documented influence ACE-inhibitors oxidative stress stratify patient prior ACE-inhibitor use randomization . All include patient randomize treatment simvastatin 40 mg daily atorvastatin 10 mg daily order achieve comparable lipid reduction . Established parameter oxidative stress , oxidize LDL , malondealdehyde measure ( 14-18 ) plasma inclusion , one week , six week three month inclusion . Primary end point study absolute difference oxidize LDL reduction two group . We also plan measure endothelial function parameter soluble Vascular Adhesion Molecule ( sVCAM ) von Willebrand factor . In addition parameter inflammation high sensitive c-reactive protein , TNF-alfa Interleuking-6 also measure investigate whether correlation eventual oxidative stress lower endothelial function inflammation . The inhibitory effect HDL prevent oxidation LDL determine measurement lipid peroxide form vitro oxidation LDL co-incubated HDL . The anti-inflammatory property HDL test measurement HDL capacity inactivate oxidize palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine ( ox-PAPC ) . For measurement use cell-free assay develop Navab co-worker ( 19 ) . Collections 24 hour urine begin one week , three month use measure urine F2-isoprostane level ( 20-24 ) . Power calculation : The number patient need detect absolute Oxidized LDL difference 9 U/L two group 3 month power 80 % , Î± 0.05 SD 12 30 patient per group .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Diabetes mellitus Hypertension chronic kidney disease K/DOQI stage 5 use statin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>simvastatin , atorvastatin , oxidative stress</keyword>
</DOC>